Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn CofiledCriticalUpjohn Co
Publication of ZA721489BpublicationCriticalpatent/ZA721489B/en
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
Health & Medical Sciences
(AREA)
Chemical & Material Sciences
(AREA)
Medicinal Chemistry
(AREA)
Pharmacology & Pharmacy
(AREA)
Epidemiology
(AREA)
Life Sciences & Earth Sciences
(AREA)
Animal Behavior & Ethology
(AREA)
General Health & Medical Sciences
(AREA)
Public Health
(AREA)
Veterinary Medicine
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
ZA721489A1971-03-291972-03-068-chloro-1-methyl-6-(o-chlorophenyl)-4h-s-triazolo(4,3-a)(1,4)benzodiazepine compositions and method of treatment
ZA721489B
(en)